Logo

Affy Sequencing Patent Tops Most-Read GenomeWeb News Stories Last Week

Jul 03, 2006

NEW YORK, July 3 (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, June 30.

 

 

1.   New Affymetrix Patent Could Cause Trouble for Next-Gen Sequencing Players (from June 29)

2. Invitrogen, Affy, Sigma-Aldrich Among Vendors to Occupy New Nasdaq Tier (from June 28)

3. Next-Gen Sequencers, Led by 454's GS20, Gain Ground in Small-RNA Analysis (from June 26)

4. Epigenomics and Sanger Institute Release First Results from Human Epigenome Project (from June 26)

5. Fisher Subsidiary Abgene Licenses ABI Tech to Offer PCR-related Products, Develop Its Own (from June 29)

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.